Evaluation of Botulinum TOXin Type A in the Treatment of Buerger's Disease
Conditions: Buerger Disease; Raynaud Syndrome Intervention: Drug: BOTOX INJECTION Sponsor: University Hospital, Toulouse Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 26, 2023 Category: Research Source Type: clinical trials
Individual Patient Expanded Access IND for Selexipag (Uptravi) in Participants With Non-healing Wound, Buerger's Disease
Conditions: Non-healing Wound; Thromboangiitis Obliterans Intervention: Drug: Selexipag Sponsor: Actelion Available (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 4, 2021 Category: Research Source Type: clinical trials